QVANTIG
RegisteredWord Mark
•
Ownership
BS
Owner Name
Type: Organization / Corporation
Address
Route 206 & Province Line Road
Princeton, NJ 08543
Critical Dates
First Use Date
Feb 28, 2025
Filing Date
Aug 26, 2022
Registration Date
Oct 21, 2025
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of cancer
Mark Elements
Text Mark
QVANTIG
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 08:04 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
The standard character mark QVANTIG covers pharmaceutical preparations for human use for the treatment and prevention of cancer in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Bristol-Myers Squibb Company, a Delaware corporation with principal offices in Princeton, New Jersey. The mark is registered on the Principal Register as of October 21, 2025, with first use in commerce on February 28, 2025, and no active oppositions or legal proceedings.
Recent Activity
Filed on August 26, 2022, the application overcame a non-final office action, was published for opposition on June 20, 2023, and issued a Notice of Allowance on August 15, 2023. After three extensions of time to file a Statement of Use, the SOU was accepted on October 1, 2025, leading to registration on October 21, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach